| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/02/2012 | CA2804709A1 Immunogenic anti-inflammatory compositions |
| 02/02/2012 | CA2804512A1 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| 02/01/2012 | EP2412811A1 Dna vaccine for alzheimer's disease |
| 02/01/2012 | EP2412808A1 Lh-type bispecific antibody |
| 02/01/2012 | EP2412758A1 Polyion complex comprising hydrophobized polyamino acid and use of same |
| 02/01/2012 | EP2412725A2 Antibodies against CD79b for the treatment of tumor of hematopoeitic origin |
| 02/01/2012 | EP2412722A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 02/01/2012 | EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 02/01/2012 | EP2412383A1 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
| 02/01/2012 | EP2412382A1 Recombinant Trypanosoma theileri parasite |
| 02/01/2012 | EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 02/01/2012 | EP2411503A1 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| 02/01/2012 | EP2411417A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| 02/01/2012 | EP2411415A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 02/01/2012 | EP2411414A1 Anti-fgfr3 antibodies and methods using same |
| 02/01/2012 | EP2411411A1 Novel anti-alpha5beta1 antibodies and uses thereof |
| 02/01/2012 | EP2411409A2 Antibody composition with altered fab sialylation |
| 02/01/2012 | EP2411407A1 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination |
| 02/01/2012 | EP2411125A1 Membrane evaporation for generating highly concentrated protein therapeutics |
| 02/01/2012 | EP2411088A1 Method and apparatus for the delivery of polynucleotide cancer vaccines to mammalian skin |
| 02/01/2012 | EP2411051A1 Rapid antemortem detection of infectious agents |
| 02/01/2012 | EP2411050A2 Antibody constant domain regions and uses thereof |
| 02/01/2012 | EP2411049A2 Methods and compositions for immunization against virus |
| 02/01/2012 | EP2411048A1 Adjuvanting meningococcal factor h binding protein |
| 02/01/2012 | EP2411047A1 Vaccine for protection against streptococcus suis bacteria of various serotypes |
| 02/01/2012 | EP2411046A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 02/01/2012 | EP2411045A1 Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| 02/01/2012 | EP2411044A2 Combinations including pneumococcal serotype 14 saccharide |
| 02/01/2012 | EP2411043A1 Treatment of cancer with immunostimulatory hiv tat derivative polypeptides |
| 02/01/2012 | EP2411039A2 Glycoconjugate vaccines |
| 02/01/2012 | EP2410996A2 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/01/2012 | EP2185686B1 Dendritic cells |
| 02/01/2012 | EP2176296B1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 02/01/2012 | EP2037958B1 A hybrid cell vaccine against leishmaniasis [kala-azar] |
| 02/01/2012 | EP1942924B1 Use of vaccines for the treatment/prevention of the transmission of influenza pathogens between species |
| 02/01/2012 | EP1877426B1 Method for preventing or treating m tuberculosis infection |
| 02/01/2012 | EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD |
| 02/01/2012 | EP1575610B1 Live attenuated vaccine against porcine pleuropneumonia |
| 02/01/2012 | EP1483416B1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 02/01/2012 | EP1472353B1 Group b streptococcus antigen |
| 02/01/2012 | EP1429803B1 Anti-coronavirus vaccine |
| 02/01/2012 | CN1914226B SARS-CoV抗体及其使用方法 SARS-CoV antibodies and the use of |
| 02/01/2012 | CN102341499A Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by same |
| 02/01/2012 | CN102341496A Humanized pcrv antibody having anti-pseudomonal activity |
| 02/01/2012 | CN102341406A Assembly activating protein (aap) and its use for manufacture of parvovirus particles essential consisting of vp3 |
| 02/01/2012 | CN102341121A Anti-rhesus d monoclonal antibody |
| 02/01/2012 | CN102341120A Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines |
| 02/01/2012 | CN102341097A In situ constituting vaccine for administration to predetermined herd of animals |
| 02/01/2012 | CN102337289A Prokaryotic expression of enterovirus 71 type VP1 (virus protein 1) and vaccine containing VP1 |
| 02/01/2012 | CN102337277A Propionibacterium acnes protein with immune protection function and application of coding genes of Propionibacterium acnes protein |
| 02/01/2012 | CN102337268A Human CTRP4 gene, its coding protein and their application |
| 02/01/2012 | CN102337250A Infectious bovine rhinotracheitis virus strain and preparation method and application thereof |
| 02/01/2012 | CN102337248A Recombinant baby hamster kidney (BHK) cell line capable of expressing encephalitis B virus PrM/M-E protein and application thereof |
| 02/01/2012 | CN102337218A Factor for regulating toxicity of Candida albicans and its application |
| 02/01/2012 | CN102336834A Fully human TNFalpha-Fab antibody and its PEG antibody |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336832A Heavy chain and domain antibodies |
| 02/01/2012 | CN102336822A Truncate human papilloma virus (HPV) 58 type L1 protein |
| 02/01/2012 | CN102336821A New Melan-A epitope peptide and application thereof in preventing and/or treating tumours |
| 02/01/2012 | CN102335440A Two gene vaccines containing different CpG (cytidine-phosphatte-guanonine) sequences PCV2 (porcine circovirus 2)-ORF2 and preparation process thereof |
| 02/01/2012 | CN102335437A Application of metadherin (MTDH) gene vaccine in preparation of breast cancer cell growth inhibitor |
| 02/01/2012 | CN102335428A Target nano delivery system as well as preparation method and application thereof |
| 02/01/2012 | CN102335427A Application of signal regulatory protein alpha to preparation of macrophages for preventing and treating tumors |
| 02/01/2012 | CN102335426A Traditional Chinese medicine animal health-care product for foot-and-mouth disease of cattle |
| 02/01/2012 | CN102335425A Method for preparing water/oil/water (W/O/W) animal vaccine oil emulsion adjuvant |
| 02/01/2012 | CN102335424A II type adenovirus live vector recombinant vaccine of dog for showing lyssa virus protective antigen by using IX protein |
| 02/01/2012 | CN102335423A II type adenovirus live vector recombinant vaccine of dog for showing lyssa virus protective antigen by using spike |
| 02/01/2012 | CN102335422A Recombinant phage peculiar smell removal vaccine for boars |
| 02/01/2012 | CN102335421A Attenuated salmonella inducible secretory expression oral vaccine presentation system and application thereof |
| 02/01/2012 | CN102335198A Production method for tick-borne encephalitis virus horse antiserum |
| 02/01/2012 | CN101912609B 防治绿脓杆菌感染的组合物及其制备方法 Pseudomonas aeruginosa infection prevention composition and its preparation method |
| 02/01/2012 | CN101838325B 猪用抗原呈递蛋白及其编码基因和应用 Pig protein and the gene encoding the antigen-presenting and applications |
| 02/01/2012 | CN101830968B 一种具有免疫调节作用的法氏囊七肽 Fabricius has immunomodulatory effects of a heptapeptide |
| 02/01/2012 | CN101780278B 二联手足口病灭活疫苗 Two teamed foot mouth disease vaccine |
| 02/01/2012 | CN101717779B 一种适用于炭疽抗毒素和疫苗的融合蛋白 One for anthrax antitoxin fusion proteins and vaccines |
| 02/01/2012 | CN101574517B 一种免佐剂具有防治1型糖尿病作用的免疫调节剂 A no adjuvant effect of having type 1 diabetes prevention immunomodulator |
| 02/01/2012 | CN101530613B 传染性脾肾坏病毒疫苗及其制备方法和应用 Infectious spleen and kidney bad virus vaccine and its preparation method and application |
| 02/01/2012 | CN101358225B 高唾液酸含量的免疫球蛋白抗体的制备方法与应用 Preparation of high sialic acid content and application of immunoglobulin antibody |
| 02/01/2012 | CN101161286B 水痘减毒活疫苗 Live attenuated varicella vaccine |
| 02/01/2012 | CN101113166B 肺炎嗜衣原体的一种重组主要外膜蛋白及其制备方法 An addicted Chlamydia pneumoniae recombinant major outer membrane protein and its preparation method |
| 02/01/2012 | CN101035897B 用于预防和治疗hiv感染的疫苗 For the prevention and treatment of hiv infected vaccine |
| 02/01/2012 | CN101024079B 肺炎链球菌多糖-外膜蛋白结合疫苗及制备方法 Streptococcus pneumoniae polysaccharide - outer membrane protein conjugate vaccine and its preparation method |
| 01/31/2012 | US8106168 Metalloproteinase binding proteins |
| 01/31/2012 | US8106167 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 01/31/2012 | US8106164 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106024 Method of treating cancer with an RPN2 gene expression inhibitor |
| 01/31/2012 | US8106018 Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof |
| 01/31/2012 | US8106015 Method for enhancing immune response with peptide |
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105797 Diagnostic test |
| 01/31/2012 | US8105793 Process for in vivo treatment of specific biological targets in bodily fluids |
| 01/31/2012 | US8105789 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 01/31/2012 | US8105615 Mixture cancer immunotherapy and adjuvant; anticancer agents |
| 01/31/2012 | US8105614 Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/31/2012 | US8105613 Vaccine formulation |
| 01/31/2012 | US8105612 Serum resistance factors of gram positive bacteria |
| 01/31/2012 | US8105611 Treatment of autoimmune disorder with a neurotoxin |